Ryan J. Watts
President and CEO at Denali Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Denali Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Denali Therapeutics Inc. June 3, 202697.1%
-
Denali Therapeutics Inc. June 1, 202399.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Denali Therapeutics Inc. | Gift | −32,220 | — | — |
| Jan 6, 2026 | Denali Therapeutics Inc. | Open-market sale | −35,198 | $16.50 | $580,767 |
| Jan 3, 2026 | Denali Therapeutics Inc. | Grant or award | +78,960 | — | — |
| Sep 3, 2025 | Denali Therapeutics Inc. | Gift | −50,000 | — | — |
| Jul 9, 2025 | Denali Therapeutics Inc. | Option exercise | +455,282 | $0.68 | $309,592 |
| Jul 9, 2025 | Denali Therapeutics Inc. | Option exercise | +40,000 | $5.28 | $211,200 |
| Jul 9, 2025 | Denali Therapeutics Inc. | Open-market sale | −495,282 | $15.00 | $7,429,230 |
| Jan 7, 2025 | Denali Therapeutics Inc. | Open-market sale | −7,650 | $20.81 | $159,197 |
| Jan 6, 2025 | Denali Therapeutics Inc. | Open-market sale | −29,266 | $20.22 | $591,759 |
| Jan 3, 2025 | Denali Therapeutics Inc. | Grant or award | +54,180 | — | — |
| Oct 18, 2024 | Denali Therapeutics Inc. | Option exercise | +40,000 | $0.68 | $27,200 |
| Oct 18, 2024 | Denali Therapeutics Inc. | Open-market sale | −40,000 | $27.69 | $1,107,600 |
| Aug 20, 2024 | Denali Therapeutics Inc. | Open-market sale | −2,260 | $23.79 | $53,765 |
| Mar 29, 2024 | Denali Therapeutics Inc. | Gift | −40,000 | — | — |
| Feb 13, 2024 | Denali Therapeutics Inc. | Open-market sale | −9,589 | $17.29 | $165,794 |
Questions about Ryan J. Watts
What boards is Ryan J. Watts on?
Ryan J. Watts sits on the board of Denali Therapeutics Inc.
What company is Ryan J. Watts the CEO of?
Ryan J. Watts is President and CEO of Denali Therapeutics Inc.
How long has Ryan J. Watts served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.